Sequana Medical N.V.
SEQUA.BR · BRU
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.34 | -1.15 | -1.46 |
| FCF Yield | -18.32% | -27.80% | -20.61% | -17.39% |
| EV / EBITDA | -8.53 | -4.19 | -4.64 | -6.12 |
| Quality | ||||
| ROIC | 544.27% | 2,341.82% | -181.60% | -435.73% |
| Gross Margin | -2,092.45% | 76.95% | 77.83% | 79.31% |
| Cash Conversion Ratio | 0.46 | 0.89 | 0.89 | 1.00 |
| Growth | ||||
| Revenue 3-Year CAGR | -51.39% | 24.34% | -1.42% | -27.46% |
| Free Cash Flow Growth | 31.10% | -5.74% | -17.61% | -39.67% |
| Safety | ||||
| Net Debt / EBITDA | -2.09 | -0.51 | 0.04 | 0.07 |
| Interest Coverage | -0.71 | -6.88 | -31.93 | -39.56 |
| Efficiency | ||||
| Inventory Turnover | 0.01 | 0.07 | 0.08 | 0.04 |
| Cash Conversion Cycle | 3,204.19 | -958.55 | -920.58 | 122.83 |